Our expansive research facilities, state-of-the-art technologies and unique location within The Royal Children’s Hospital, are some of the reasons we’re home to over 1,800 leading researchers and scientists.
Stay informed with the latest research insights, technological advancements and innovations in child health from our research and scientific community.
Discover how you can support us and our partners to help our researchers make life-changing breakthroughs for children.
Search throughout the entire MCRI website to find exactly what you are looking for.
The Neonatal research group at the Murdoch Children’s Research Institute (MCRI) is dedicated to improving the treatment and long-term outcomes of ill newborn infants.
Our group explores Developmental Haemostasis (how the blood’s clotting system matures with age). We use the power of laboratory and clinical expertise to improve the lives of children.
Advancing orthopaedic care for children through research and innovation. We are dedicated to improving outcomes for children with bone, muscle, and joint conditions.
Improving emergency care for children through research and national and international collaboration.
Our research explores clinical and translational outcomes in paediatric social work and infant mental health.
To improve the lives of children with brain injury by contributing to the development of knowledge in the field at the level of theory, practice, and implementation.
Anaesthetics & Pain research group is dedicated to enhancing the quality of care for children before, during, and after surgery. Our research focuses on understanding how young patients respond to anaesthesia and pain management, with the goal of improving clinical practices and long-term
Researchers from Murdoch Children’s Research Institute (MCRI) have received a $100,000 donation from The Gillin Boys Foundation to support research into Duchenne Muscular Dystrophy (DMD). On Thursday 11 May, Drs Peter Houweling and Chantal Coles visited The Gillin Boys Foundation and its
Most children with COVID-19 in Australia don’t require hospital treatment, according to a new study, which may help ease the demand on emergency departments this winter.
A study has found after one year of wearing a Viaskin Peanut epicutaneous immunotherapy (EPIT) patch, that young children had decreased likelihood of experiencing an allergic reaction following accidental peanut exposure.
Page 56 of 257
